Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1999-2-11
pubmed:abstractText
Tetanus toxin (TeTx) is a powerful clostridial neurotoxin that inhibits Ca2+-dependent neurotransmitter secretion as do the botulinum neurotoxins (BoNTs). We found that TeTx (but not BoNT/A) produced a specific time- and dose-dependent inhibition of Na+-dependent [3H]5-hydroxytryptamine (serotonin, 5-HT) uptake in rat CNS synaptosomes. This effect was found in all CNS tryptaminergic areas, being maximal in the hippocampus and occipital cortex. TeTx produced the maximum reduction in [3H]5-HT uptake after 30 min of preincubation, being significant also at lower doses (10(-12) M) or shorter incubation times (10 min). Serotonin transport inhibitors such as fenfluramine (IC50, 11.0 +/- 0.9 microM), paroxetine (IC50, 33.5 +/- 0.1 microM), and imipramine (IC50, 89.9 +/- 5.7 microM) were 3 or 4 orders of magnitude less potent than TeTx (IC50, 8.7 +/- 1.0 nM). Of the two fragments of TeTx, (the C-terminal portion of the neurotoxin heavy chain, which is responsible for the binding to the nerve tissue) was consistently more effective than the L-H(N) fragment (the light neurotoxin chain disulfide linked to the N-terminal portion of the heavy chain, which is responsible for the toxic metalloprotease action) as inhibitor of [3H]5-HT uptake in synaptosomal preparations (56 +/- 5% and 95 +/- 3% with respect to control, respectively). Antagonism of the toxin-induced [3H]5-HT uptake blockade could not be reversed by zinc chelators but did have the ability to antagonize the TeTx inhibition of basal and K+-evoked [3H]5-HT release in rat synaptosomes. The reduction in serotonin accumulation induced by TeTx could be responsible for some tetanic symptoms that have been related to the serotonergic system.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0006-2952
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
111-20
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:9920291-Animals, pubmed-meshheading:9920291-Biological Transport, pubmed-meshheading:9920291-Botulinum Toxins, pubmed-meshheading:9920291-Brain, pubmed-meshheading:9920291-Captopril, pubmed-meshheading:9920291-Fenfluramine, pubmed-meshheading:9920291-Imipramine, pubmed-meshheading:9920291-Kinetics, pubmed-meshheading:9920291-Male, pubmed-meshheading:9920291-Organ Specificity, pubmed-meshheading:9920291-Paroxetine, pubmed-meshheading:9920291-Phenanthrolines, pubmed-meshheading:9920291-Rats, pubmed-meshheading:9920291-Rats, Sprague-Dawley, pubmed-meshheading:9920291-Serotonin, pubmed-meshheading:9920291-Serotonin Uptake Inhibitors, pubmed-meshheading:9920291-Sodium, pubmed-meshheading:9920291-Synaptosomes, pubmed-meshheading:9920291-Temperature, pubmed-meshheading:9920291-Tetanus Toxin, pubmed-meshheading:9920291-Tritium
pubmed:year
1999
pubmed:articleTitle
Inhibition by tetanus toxin of sodium-dependent, high-affinity [3H]5-hydroxytryptamine uptake in rat synaptosomes.
pubmed:affiliation
Department de Bioquímica i de Biologia Molecular, Facultat de Medicina, Universitat Autonoma de Barcelona, Bellaterra, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't